PRIMING REDUCES THE BONE-MARROW TOXICITY OF CARBOPLATIN

被引：6

作者：

GORE, ME

HILLS, CA

SIDDIK, ZH

SLOANE, JP

WINKLEY, AR

SMITH, IE

MILLAR, JL

机构：

[1] ROYAL MARSDEN HOSP,INST CANC RES,SUTTON SM2 5PT,SURREY,ENGLAND

[2] ROYAL MARSDEN HOSP,LUNG UNIT,SUTTON SM2 5PT,SURREY,ENGLAND

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 01期

关键词：

D O I：

10.1016/0277-5379(87)90422-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：75 / 80

页数：6

共 21 条

[1]

BERGSAGEL DE, 1971, CAN MED ASS J, V33, P31

[2] PHASE-I STUDIES WITH CARBOPLATIN AT THE ROYAL-MARSDEN-HOSPITAL [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

HARRAP, KR .

CANCER TREATMENT REVIEWS, 1985, 12 :51-57

[3]

CROCKER CL, 1967, AM J MED TECHNOL, V33, P361

[4]

EVANS BD, 1983, CANCER TREAT REP, V67, P997

[5] HIGH-DOSE CYCLOPHOSPHAMIDE TREATMENT OF HUMAN OAT-CELL XENOGRAFTS IN IMMUNE DEPRIVED MICE [J].

EVANS, BD ;

SMITH, IE ;

MILLAR, JL .

BRITISH JOURNAL OF CANCER, 1983, 47 (02) :215-219

[6] A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE PRETREATMENT (PRIMING) BEFORE SHORT-DURATION CHEMOTHERAPY FOR SMALL CELL LUNG-CARCINOMA [J].

HARLAND, S ;

PEREZ, D ;

MILLAR, J ;

SMITH, I .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (01) :61-64

[7]

HEDLEY DW, 1978, LANCET, V2, P966

[8]

KULKARNI SS, 1985, CANCER RES, V45, P5431

[9]

MARSH JC, 1982, CANCER RES, V36, P1853

[10] THE CONCEPT OF PRIMING [J].

MILLAR, JL ;

MCELWAIN, TJ .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (11) :1303-1305

← 1 2 3 →